[Antineoplasic drug repurposing in hematology for COVID-19 treatment].

Tazi, Illias

[Antineoplasic drug repurposing in hematology for COVID-19 treatment]. / Repositionnement des antinéoplasiques utilisés en hématologie dans le traitement du COVID-19.

Tazi, Illias.

Tazi I; Université Cadi Ayyad, faculté de médecine, CHU Mohamed VI, service d'hématologie clinique, Marrakech, Maroc. Electronic address: tazi_illias@hotmail.com.

Bull Cancer ; 108(4): 435-437, 2021 Apr.

Article in French | MEDLINE | ID: covidwho-1118340

Subject(s)

COVID-19 Drug Treatment; Drug Repositioning; Hematologic Neoplasms/drug therapy; Adenine/analogs & derivatives; Adenine/therapeutic use; Aniline Compounds/therapeutic use; Humans; Imatinib Mesylate/therapeutic use; Janus Kinases/antagonists & inhibitors; Nitriles/therapeutic use; Oligopeptides/therapeutic use; Piperidines/therapeutic use; Protein Kinase Inhibitors/therapeutic use; Pyrazoles/therapeutic use; Pyrimidines/therapeutic use; Quinolines/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / Drug Repositioning / COVID-19 Drug Treatment Limits: Humans Language: French Journal: Bull Cancer Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google